Fig. 7From: MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progressionMiR-23b downregulated CCNG1 expression in tumor xenografts in vivo. IF experiments indicated that CCNG1 expression in the tumor xenografts of miR-23b–treated nude mice were decreased compared with that in the mock-treated nude miceBack to article page